Research Article
“Keeping the Boogie Man Away”: Medication Self-Management among Women Receiving Anastrozole Therapy
Table 2
The women’s self-reported side effects.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Arthralgias were defined as aches, pains, and joint pains. “Female things” were defined as vaginal itching, vaginal bleeding, vaginal discharge, or pain with intercourse. B: Symptoms reported by the participant on the Breast Cancer Prevention Trial (BCPT) Symptom Checklist only. I: Symptoms reported by the participant during the interview only. Both: Symptoms reported by the participant in both the interview and the BCPT. P: Anxiety reported by the participant in the Profile of Mood States (POMS) Tension-Anxiety Subscale. BDI-II: Depressive symptoms reported by the participant in the Beck Depression Inventory-II Scale. *This participant was the only woman to specifically express depressive symptoms or anxiety in her interview. |